Fig. 3From: Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessusCytotoxic and hemolytic activity of the arenicin and arenicin-Abu peptides. A–C Cytotoxicity dose–response curves following 48 h-exposure to increasing concentrations of each peptide on human A BEAS-2B cells, B HepG2 cells, and C A498 cells. D Dose–response curves for human erythrocyte hemolysis after exposure to increasing concentrations of each peptide. Results are expressed as the mean ± SD of three independent experimentsBack to article page